Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Respiratory Distress Syndrome Due to Disease Caused by 2019-nCoV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04416139
What this trial is testing

Mesenchymal Stem Cell for Acute Respiratory Distress Syndrome Due for COVID-19

Who this might be right for
Covid 19
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 10
Testing effectiveness (Phase 2)UnknownNCT04397497
What this trial is testing

Mavrilimumab in Severe COVID-19 Pneumonia and Hyper-inflammation (COMBAT-19)

Who this might be right for
Covid-19Acute Respiratory FailureARDS, Human+2 more
Ospedale San Raffaele 50
Not applicableUnknownNCT04568018
What this trial is testing

Surfactant-BL in Adult Acute Respiratory Distress Syndrome Due to COVID-19

Who this might be right for
ARDS Due to COVID-19
Biosurf LLC. 120
Not applicableEnded earlyNCT04397172
What this trial is testing

Intensive Care Associated Complications and Outcome of Acute Respiratory Distress Syndrome Due to COVID-19

Who this might be right for
COVIDCorona Virus InfectionSars-CoV2
Insel Gruppe AG, University Hospital Bern 48